Corcept Therapeutics, Inc. (CORT) Tops Q3 EPS by 1c
Tweet
Share
E-mailGet Alerts CORT Hot Sheet
Price: $115.84 -1.42%
EPS Growth %: +406.3%
Financial Fact:
Loss from operations: 3.07M
Today's EPS Names:
OCCI, ALZN, ASPU, More
EPS Growth %: +406.3%
Financial Fact:
Loss from operations: 3.07M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Corcept Therapeutics, Inc. (NASDAQ: CORT) reported Q3 EPS of ($0.08), $0.01 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $1.05 million versus the consensus estimate of $2.07 million.
For earnings history and earnings-related data on Corcept Therapeutics, Inc. (CORT) click here.
For earnings history and earnings-related data on Corcept Therapeutics, Inc. (CORT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Paychex (PAYX) Tops Q1 EPS by 2c
- AutoZone (AZO) PT Lowered to $4,230 at UBS Following 'Underwhelming' Q4 Print
- Royal Caribbean to acquire 50% stake in Sandals Resorts for $3 billion
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
